Prodrugs design based on inter- and intramolecular chemical processes
1Bioorganic Chemistry Department, Faculty of Pharmacy, Al-Quds University, P.O. Box 20002, Jerusalem, Palestine; Department of Science, University of Basilicata, Via dell'Ateneo Lucano 10, 85100, Potenza, Italy.
Chemical Biology & Drug Design
|September 4, 2013
Summary
This review explores modern prodrug design strategies, focusing on enzyme-catalyzed chemical approaches and computational methods like DFT for optimizing drug properties and understanding enzymatic catalysis.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Design
Background:
- Prodrugs are crucial for improving drug physicochemical properties.
- Enzyme-catalyzed chemical approaches are widely used in prodrug design.
- Computational methods offer novel avenues for prodrug development.
Purpose of the Study:
- To provide an overview of prodrug approaches, emphasizing modern design strategies.
- To discuss the role of enzyme-catalyzed reactions in prodrug development.
- To highlight the application of computational chemistry in designing novel prodrugs.
Main Methods:
- Review of existing prodrug strategies.
- Discussion of enzyme-catalyzed prodrug activation mechanisms.
- Application of molecular orbital methods (DFT, semiempirical, ab initio) and molecular mechanics (MM2) for prodrug design.
- Correlation of computational data with experimental findings.
Main Results:
- Enzyme-catalyzed approaches effectively minimize undesirable drug properties.
- Computational methods, including DFT, enable the design of novel prodrugs.
- Enzyme models can mimic enzymatic catalysis for prodrug design.
- Understanding intramolecular processes aids in optimizing reaction rates and enzyme catalysis.
Conclusions:
- Modern prodrug design increasingly relies on computational approaches.
- The integration of computational chemistry and enzyme mimicry offers powerful tools for developing improved therapeutics.
- Further research into computational methods will enhance the understanding and application of prodrug strategies.
Related Concept Videos
Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

